Taro Pharmaceuticals Inc. Product Recall (2020-07-20)
- Starting date:
- July 20, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73615
Last updated: 2020-07-24
Summary
- Product: A. Dermovate Cream B. Taro-Clobetasol Cream USP, 0.05%
- Dermovate Cream
- Taro-Clobetasol Cream USP, 0.05%
Reason
The content uniformity may be out of specification in the affected lots.
Depth of distribution
Wholesalers
Affected products
Dermovate Cream
DIN, NPN, DIN-HIM
DIN 02213265Dosage form
Cream
Strength
Clobetasol Propionate, 0.05%
Lot or serial number
AB40179
Companies
- Recalling Firm
-
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Taro-Clobetasol Cream USP, 0.05%
DIN, NPN, DIN-HIM
DIN 02245523Dosage form
Cream
Strength
Clobetasol Propionate, 0.05%
Lot or serial number
AB28534
AB27927
Companies
- Recalling Firm
-
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Taro Pharmaceuticals Inc.
126 East Drive
Brampton
L6T 1C1
Ontario
CANADA